Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Navigator Formed to Develop Korea’s IMBiologics Immune Portfolio

publication date: Aug 27, 2024

New Jersey’s Navigator Medicines raised $100 million in an initial funding to develop an OX40L-targeted portfolio that was in-licensed from Korea’s IMBiologics. RA Capital Management and Forbion, a Dutch life sciences investor, formed Navigator and initiated the agreement with IMBiologics earlier this year, signing a $995 million agreement for global rights (ex-Asia) to the immune disease candidates. Last week, IMBiologics out-licensed China rights for the dual targeting molecule to Hangzhou’s Huadong Pharmaceutical in a $383 million agreement. IMBiologics is currently conducting a Phase I trial of the candidate in the US among healthy volunteers. More details....

Share this with colleagues:  



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here